Tirzepatide
FDA labeling and large randomized trials exist for specific labeled indications under medical supervision.
FDA Labeling SURMOUNT-1 TrialYou must be 21 years of age or older to enter this website.
PREMIUM PEPTIDES • FAST SHIPPING QUALITY PRODUCTS • SECURE CHECKOUT
Learn moreFrequently Asked Questions
Find organized answers about products, documentation, ordering, shipping, privacy, and responsible information.
WCPS FAQ
Six organized sections designed to make important information easier to review.
Browse QuestionsImportant Information
Research status, regulatory policy, and product documentation can change. Review current source material before relying on product-specific information.
General Information
It means the catalog and educational content are presented for research and development context only. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, mitigation, or prevention of disease.
No. West Coast Peptide Sciences does not provide instructions for human or veterinary use, including dosing, administration, reconstitution, treatment protocols, or performance guidance.
No. Educational material on this website is not medical advice, a diagnosis, a treatment recommendation, or a substitute for a licensed healthcare professional.
No. Published findings are specific to the study design, molecule, formulation, population or model, dose, endpoints, and limitations of that work.
Research Context
No. FDA-approved drug products have specific manufacturing, labeling, quality, safety, and prescribing controls. A catalog listing should not be represented as equivalent to an approved prescription product.
Tirzepatide is the active ingredient in certain FDA-approved prescription products for labeled indications. Those approvals do not make a separate catalog listing interchangeable with an approved product.
Retatrutide is presented here as investigational. Published research and trial registries are educational sources, not approval, treatment, or safety claims.
The available literature differs substantially by compound, formulation, route, model, and research question. Each material requires molecule-specific review.
Reference Material
These links allow readers to inspect primary or authoritative source material. They are not product instructions, guarantees, or promises of outcomes.
FDA labeling and large randomized trials exist for specific labeled indications under medical supervision.
FDA Labeling SURMOUNT-1 TrialInvestigational triple receptor agonist research; review the study publication and current trial registry.
Phase 2 Publication ClinicalTrials.govLiterature is heavily preclinical, and FDA materials identify safety-data concerns in the compounding context.
FDA Context PubMed SearchDirect TB-500-specific human evidence is limited. Preclinical findings should not be converted into human-use claims.
PubMed SearchResearch spans peptide biology and topical or cosmetic contexts. Those findings should not be extrapolated into systemic-use claims.
PubMed SearchMOTS-c is a mitochondrial-derived peptide with substantial preclinical interest; human evidence remains limited.
Foundational Publication PubMed SearchQuality Information
Yes, we frequently update COA's for reference after testing batches. At West Coast Peptides we maintain a high level of quality control and demand the highest quality of product purity with no heavy metal contamination or endotoxins. See the Certificates of Analysis section for our most current certificate of analysis.
No. An analytical document does not establish safety, efficacy, clinical suitability, or approval for human or veterinary use.
Responsible communication distinguishes published research from a specific catalog item’s manufacturing, formulation, documentation, legal status, and intended use.
Customer Protection
Do not send payment-card details, passwords, recovery codes, government IDs, medical records, or other sensitive personal information through ordinary email.
Use only contact channels and domains published on this website. Be cautious of unsolicited messages, look-alike domains, or unusual payment requests.
Use the website contact page with the subject line “Security concern.” Preserve screenshots, sender addresses, URLs, and order references where applicable.
Published privacy, payment, shipping, return, and terms policies should be reviewed before using the website or completing a transaction.
Responsible Information
This website does not claim that any material diagnoses, treats, cures, mitigates, or prevents disease or guarantees individual outcomes.
Eligibility rules vary by substance, sport, governing body, and jurisdiction. Review the current World Anti-Doping Agency Prohibited List and the applicable governing body’s rules.
Regulatory requirements and policies change. Review current authority materials and consult qualified legal or regulatory counsel when necessary.
Final Note
Information on this page is educational and should be reviewed as policies, product documentation, and regulatory guidance change.